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The prevailing mechanism for recurrent and
some nonrecurrent rearrangements causing
genomic disorders is nonallelic homologous
recombination (NAHR) between region-specific
low-copy repeats (LCRs). For other nonrecur-
rent rearrangements, nonhomologous end join-
ing (NHEJ) is implicated. Pelizaeus-Merzbacher
disease (PMD) is an X-linked dysmyelinating
disorder caused most frequently (60%–70%)
by nonrecurrent duplication of the dosage-sen-
sitive proteolipid protein 1 (PLP1) gene but also
by nonrecurrent deletion or point mutations.
Many PLP1 duplication junctions are refractory
to breakpoint sequence analysis, an observa-
tion inconsistent with a simple recombination
mechanism. Our current analysis of junction se-
quences in PMD patients confirms the occur-
rence of simple tandem PLP1 duplications but
also uncovers evidence for sequence complex-
ity at some junctions. These data are consistent
with a replication-based mechanism that we
term FoSTeS, for replication Fork Stalling and
Template Switching. We propose that complex
duplication and deletion rearrangements asso-
ciated with PMD, and potentially other nonre-
current rearrangements, may be explained by
this replication-based mechanism.
INTRODUCTION
Structural variation of the human genome can be associ-
ated with disease traits or represent benign copy-number
variation (CNV) (Lee and Lupski, 2006; Lupski, 2007). Ge-
nomic disorders are a group of human genetic diseases
caused by DNA rearrangements that result in the gain,
loss, or disruption of a gene(s) for which dosage is criticalCell 1(Lupski, 1998; Lupski and Stankiewicz, 2005, 2006). These
disorders are often characterized by similar genomic
features in the rearrangement-susceptible regions but rep-
resent a wide spectrum of unrelated clinical entities.
The recombination mechanisms nonallelic homologous
recombination (NAHR) and nonhomologous end joining
(NHEJ) have been shown to underlie the rearrangements
causing genomic disorders (Shaw and Lupski, 2004),
with the former accounting for the majority. NAHR can
use either region-specific low-copy repeats (LCRs, or seg-
mental duplications) or sometimes repetitive sequences
(e.g., Alu) as homologous recombination substrates,
yielding recurrent events with clustered breakpoints.
Much less is known about the mechanism(s) for nonrecur-
rent rearrangements. NHEJ has been implicated for sev-
eral such disorders (Inoue et al., 2002; Padiath et al.,
2006; Shaw and Lupski, 2005; Toffolatti et al., 2002). How-
ever, a number of disease-associated rearrangements are
not explained readily by either the NAHR or simple NHEJ
recombinational mechanisms.
To elucidate the molecular mechanism responsible for
nonrecurrent rearrangements, we focused on the duplica-
tions associated with the genomic disorder Pelizaeus-
Merzbacher disease (PMD). PMD is an X-linked recessive
dysmyelinating disorder caused most frequently (60%–
70%) by nonrecurrent duplication of the dosage-sensitive
proteolipid protein 1 (PLP1) gene but also by nonrecurrent
PLP1deletion or point mutations (Inoue et al., 1999; Sister-
mans et al., 1998). PLP1 rearrangement breakpoint
junction analyses reveal microhomology or a lack of
homology (Inoue et al., 2002; Woodward et al., 2005) char-
acteristic of nonrecurrent rearrangement junctions; as re-
ported in the literature, such products of recombination
are consistent with NHEJ repair. However, other genomic
rearrangement mechanisms requiring microhomology are
also possible.
We performed high-resolution oligonucleotide (oligo)
array comparative genomic hybridization (CGH) and
breakpoint sequence analyses of PMD-associated PLP1
nonrecurrent duplications. To our knowledge, there have
been no such combined analyses performed to date on31, 1235–1247, December 28, 2007 ª2007 Elsevier Inc. 1235
any genomic disorder due to nonrecurrent duplications.
From our analyses, we identified the extent of genomic
gain/loss and determined junction sequences in PMD
patients with different-sized (200 kb to 7 Mb) genomic
rearrangements. To our surprise, we uncovered inter-
spersed stretches of DNA of normal copy number or trip-
licated but contained within duplicated sequence and
sequence complexity at the junctions. These findings sug-
gest parsimoniously an alternative mechanism involving
errors of DNA replication, instead of the more generally
considered meiotic recombination mechanisms (NAHR
and NHEJ). Our model of replication Fork Stalling and
Template Switching (FoSTeS) can explain the complex
duplication and deletion rearrangements associated with
PMD and potentially other nonrecurrent rearrangements
of the human genome.
RESULTS
Semiquantitative PCR Delimits Apparent
Duplication Junction Regions
By semiquantitative multiplex PCR analyses, using our
previously published BAC array comparative genomic hy-
bridization (CGH) data (Lee et al., 2006a) as a starting point,
we delineated PLP1 duplication boundaries effectively for
all patients studied (Table 1). From the positions of the fur-
thest-apart primers that detected a DNA duplication (i.e.,
primers closest to the duplication boundaries and con-
tained within the duplicated region), we calculated the ap-
proximate size of the duplicated region(s) for each patient
(Table 1) with greater resolution than possible by BAC array
CGH analysis. The precise locations of those breakpoints
were narrowed to within 160 bp to 64 kb (Table 1).
Novel Duplication Junctions Identified
by Long-Range PCR and DNA Sequencing
Long-range PCR was attempted initially, under the as-
sumption of direct or tandem duplication (Inoue et al.,
1999), on eight selected patient samples for which there
was no evidence of complex rearrangement by previous
methods (Lee et al., 2006a) (Table 1). The furthest-apart
semiquantitative multiplex PCR primers (outward-facing
relative to reference sequence) that detected a duplicated
genomic sequence were used to amplify duplication junc-
tions (Table S1 available online). Junction sequence was
successfully amplified and sequenced for two patients,
BAB1258 and 1264. No significant homology was found
within 2 kb to either side of these junctions in the reference
human genome sequence by BLAST2 analysis.
Southern Blot Analyses Detect Junction
Fragments in the Remaining Patients
For the remaining six patients (BAB1707, 2448, 1301,
1290, 1275, and 1327) for whom no duplication junction
amplification product was detected, we performed geno-
mic Southern blot analysis (Table S2 and Figure S1) to
confirm junction location. Changes in the sizes of the
restriction digest fragments relative to those predicted1236 Cell 131, 1235–1247, December 28, 2007 ª2007 Elsevierby the reference sequence were observed, reflecting (1)
the addition or deletion of sequence at a novel junction,
(2) the relative position of the breakpoint to the nearest
restriction site, or (3) polymorphisms (i.e., RFLPs) at the re-
striction sites.
Enrichment of novel restriction fragments followed by
inverse, TOPO linker-mediated, VISA, and DOP PCR
methodologies (See Supplemental Experimental Proce-
dures) did not allow us to identify the breakpoints for these
remaining six patients.
Oligonucleotide Array CGH Enables Higher-
Resolution Breakpoint Junction Mapping
We designed a custom Agilent array consisting of 44,000
(44K) oligos tiling an 10 Mb genomic region including
PLP1, at a resolution of 1 interrogating oligo every
500 bp. By this analysis we determined that the majority
of our patients may have undergone complex rearrange-
ments. We found evidence for the expected simple
tandem duplications as well as interrupted duplications
in which stretches of duplicated DNA were punctuated
by stretches of DNA with no copy-number alteration (Fig-
ure 1). Further, as observed by other groups (Wolf et al.,
2005), copy-number changes suggestive of triplicated or
quadruplicated sequences contained within duplicated
segments, for which the log2 (Cy3/Cy5) ratios approached
1.6 and 2.0, respectively, rather than the expected 1.0 for
duplicated regions, were identified (Figure S2). These data
are summarized in Figure 2. Because interrogating oligos
were designed to exclude repeat-masked DNA, some
coverage gaps exist for which no copy-number informa-
tion could be obtained. Nevertheless, the genome resolu-
tion enabled by oligo array CGH analysis was significantly
greater than that achieved previously by BAC array CGH
(Lee et al., 2006a) and semiquantitative multiplex PCR
methodologies. This analysis revealed rearrangements
more complex than simple tandem duplications in at least
11 of 17 (65%) patients tested.
However, once oligo array CGH was performed and
long-range PCR was attempted based on more refined
copy-number boundary delineation, we experienced sim-
ilar difficulty in amplifying across duplication junctions,
except for patient BAB2448 (discussed below). Despite
our high-resolution analysis, for the majority of patients
amplification of the rearrangement junctions was not
achieved, making simple tandem duplications improbable
and suggesting complex rearrangements in these pa-
tients. Overall, our success rate (3/17 = 18%) of effectively
sequencing novel PLP1 duplication junctions is similar to
that of other groups (Woodward et al., 2005).
Junction Sequences Reveal Complex
Rearrangements
From our junction analysis, we conclude that the rear-
rangement in patient BAB1258 may be a simple tandem
duplication (Figures 3A and 3B), as has been identified
for most sequenced PLP1 duplications (Inoue et al.,
1999; Woodward et al., 2005). Further, two base pairs ofInc.
Table 1. Junction Analysis of Selected PLP1 Duplications from Patients with PMD
Patient
(BAB#)
Rearrang.
Spana
Apparent Junction
Position(s) (Build 35)
No. of
Junctionsb
Nature of
Rearrang.a
1264c 180 kb 102883770::102370246; 102730277::102726973;
102727187::102712464
3 Complex
1258c 190 kb 102665716::102855124 1 Noncomplex
1707c,d 400 kb 102640944-102647753; 103049282-103049439 R1 Noncomplex
2448c,d 420 kb 103005282::102579802; 102782479-102783321;
102790832-102791889; 102950000-102963000;
102981000-102982000
R3 Complex
H152c 430 kbe 102817314::103369461; 103369494::103246266;
103096667-103099990; 103110000-103138000;
103009450-103021026; 103029644-103049223
R4 Complex
1334f 460 kb 102623208-102624396; 103029776-103049223;
103075656-103079184; 103108655-103145524
R2 Complex
1482f 500 kb 102587535-102589735; 103029644-103049223;
103071867-103073186; 103110848-103143639
R2 Complex
1301c,d 560 kb 102464125-102465370; 102636000-102637000;
102647000-102648000; 102892309-102893118;
102893904-102894913; 103029807-103049439
R3 Complex
1261f 580 kb 102526363-102528665; 103109525-103146062 R1 Complex
1305f 600 kb 102462505-102464066; 102636862-102638227;
102646604-102647086; 103016000-103049223
R2 Complex
1282f 660 kb 102471795-102480245; 103080000-103143639 R1 Complex
1290c,d 800 kb 102333875-102335628; 102917881-102942038;
103029644-103049223; 103103514-103109476
R3 Complex
1275c,d 970 kb 102164207-102167232; 102231681-102235383;
102256404-102258043; 102782849-102783912;
102791320-102792583; 103103514-103108463
R3 Complex
1420f 1 Mb 102524657-102527322; 103559197-103560962 R1 Noncomplex
2389f 4 Mb 99191746-99210640; 102880716-102886748;
102940000-102959000; 102985000-102990000;
103029244-103063198; 103107915-103143639
R4 Complex
1327c,d 7.3 Mb 99252780-99254843; 106569573-106570347 R1 Noncomplex
2396f 7.8+ Mbg 100196711-100201345; 103028718-103071407;
103107915-103143639
R3 Complex
Rearrang., rearrangement; ::, exact breakpoint junction positions as determined by sequence analysis; other values are junction
regions narrowed by array CGH analysis.
a As determined by semiquantitative multiplex PCR, array CGH, previous PFGE analyses, and/or DNA sequencing.
b Number of junctions sequenced/predicted based on array data.
c Selected for breakpoint delineation by semiquantitative multiplex PCR.
d Selected for breakpoint analysis by inverse, TOPO-linker mediated, VISA, and DOP PCR.
e Harbors a deletion of 190 kb including PLP1.
f Analyzed only by array CGH and long-range PCR.
g Duplication extends beyond region interrogated by array.microhomology were identified at this junction, consistent
with NHEJ repair as has been proposed previously for
PLP1 rearrangements (Inoue et al., 2002; Woodward
et al., 2005).
By oligo array CGH analysis, we determined that there is
an interrupted duplication that occurred in patient
BAB2448, as there are three duplicated segments thatCell 1flank smaller segments with no copy-number alteration.
Centromeric to telomeric, we observed a 200 kb dupli-
cated segment, followed by 9 kb with no copy-number
change, an 170 kb duplicated segment, an 15 kb seg-
ment with no copy-number change, and finally a 20 kb du-
plicated segment. Overall, the duplications span 420 kb
and appear to be complex. One junction was identified for31, 1235–1247, December 28, 2007 ª2007 Elsevier Inc. 1237
Figure 1. Complex Interrupted Duplications Revealed by Oligonucleotide Array CGH
Copy-number alteration data for patients: (A) 2448, (B) 1334, (C) 1482, (D) 1301, (E) 1305, and (F) 1275 are shown. Array data for patients 1264 and
1258 (Figure S3), 1707, 1261, 1282, and 1420 did not reveal obvious complex rearrangements (not shown). Displayed are copy-number changes ob-
served, with enlargements of each area depicting regions of no copy-number change flanked by duplicated sequence below. Red data points indicate
copy-number gains, green data points losses, and black data points no copy-number change. In each horizontal yellow box above, blue lines rep-
resent an average of the data points; log2 (Cy3/Cy5) values are on the y axis; genomic position in megabases (Mb; NCBI build 35) is on the x axis.this patient, with five base pairs of microhomology (Table
S3A; Figures 3C and 3D). Visually, it appears that a DNA
replication fork ‘‘skipped backward’’ and then ‘‘skipped
forward’’ along the chromosome (Figure 3E), similar to
the proposed mechanism for the rearrangement in patient
BAB1264 (see below).
The duplication rearrangement that occurred in patient
BAB1264 also appears to be complex, as additional short
sequences, or ‘‘junctional’’ sequences, were found at the
duplication junction; a total of three junctions were identi-
fied for this patient (Figure 4). Interestingly, these junctional
sequences (32 bp and 215 bp) were found to have 100%
shared identity to regions contained within the duplicated
segment. More interesting are the order and direct orienta-
tion, with respect to the positive strand, of these two junc-1238 Cell 131, 1235–1247, December 28, 2007 ª2007 Elseviertional sequences, as graphically illustrated in Figure 4C.
Visually, it appears that a DNA replication fork skipped
backward along the chromosome. Two or three base pairs
of microhomology were identified at these junctions.
The striking assembly of unexpected additional se-
quences from discreet genomic positions at the dupli-
cation junction in patient BAB1264 and the complex
rearrangement in patient BAB2448 are difficult to explain
by either an NAHR or simple NHEJ recombinational mech-
anism.
A Complex Deletion Junction Is Inconsistent
with a Simple Recombination Model
We reanalyzed the rearrangement of one previously pub-
lished patient with a complex PLP1 deletion (Inoue et al.,Inc.
Figure 2. Comparison of Complex Genomic Rearrangements Involving PLP1
Summary of X chromosome rearrangements including PLP1 (red circle); left, patient numbers. Duplications are shown as red bars, deletions in green,
triplications in dark blue, and no copy-number change in white. Centromeric (cen) and telomeric (tel) positions are shown. Figure not drawn to scale;
approximate positions given in megabases (Mb) relative to PLP1.2002). For this patient, two junctions were previously
sequenced, revealing two base pairs of microhomology
at each with some additional unexpected sequences in
an inverted orientation (discussed below). From these
data, we predicted that there was at least one remaining
junction to be sequenced, as the distal boundary of the
deletion had not been identified yet at the sequence level.
Thus, a higher-resolution analysis of this genomic region
was applied.
Oligo array CGH analysis was performed on the DNA of
this patient’s carrier mother (H150), who harbors an iden-
tical genomic rearrangement to her son. Such an analysis
yields the same copy-number results, as the mother’s
DNA is normalized to a female control. In this family, we
confirmed the deletion of 190 kb and also identified
that it is followed by a stretch of 9 kb with no copy-
number change and duplications (80 kb and110 kb) in-
terrupted by a short stretch of DNA for which there is no
copy-number change (Figures 5A and 5B). Furthermore,
we were able to reinterpret the junctions previously re-
ported based on our new findings. Previously, the proxi-
mal (centromeric) breakpoint at the start of the 190 kb
deletion was found to be joined to a 34 bp segment that
normally maps 760 kb distal (telomeric) to PLP1, but in
an inverted orientation; this was followed by another junc-
tion with a stretch of DNA of at least 5 kb in length that
normally maps 640 kb distal to PLP1, also in an inverted
orientation. Based on NCBI build 35, a more recent ver-
sion of the draft sequence than that available when an
analysis of patient H152 was originally published, weCellfound that this R5 kb stretch of DNA currently
maps 393 kb distal to PLP1 and aligns to the distal
end of the duplication identified by our oligo array CGH
analysis. In other words, this R5 kb DNA segment is
actually part of an 110 kb duplication. A graphical illus-
tration of the rearrangement for this family is found in
Figures 5C and 5D.
Rearrangement Breakpoint Junctions
and Genome Architecture
The genomic region surrounding PLP1 contains complex
genomic architecture, such as abundant LCRs of different
sizes (1–122 kb) with high sequence identity and in var-
ious orientations (Inoue et al., 1999; Lee et al., 2006a;
Woodward et al., 2005), which may render susceptibility
to genomic rearrangement. Accordingly, we sought to
determine whether such complex architecture may play
a role in replication fork stalling and template switching.
We examined the genomic positions where the proposed
template switching has occurred in our patient cohort and
superimposed these locations on the regional genome
architecture. Most occur in proximity to LCR-PMDs (i.e.,
LCR-PMDA, B, C, D, and E2), where a replisome may
encounter complex architecture (Figure 6A). It appears
that the proposed FoSTeS events may preferentially occur
within or adjacent to complex genomic architecture that
has symmetrical features that may enable cruciform struc-
tures to form, suggesting that these events may be stimu-
lated by LCRs. We suggest that the unusual genome
architecture surrounding PLP1 may confuse the DNA131, 1235–1247, December 28, 2007 ª2007 Elsevier Inc. 1239
Figure 3. Junction Analysis for Patients
BAB1258 and 2448
(A and C) Duplication junction(s) (vertical
dotted line(s)) for patients BAB1258 and
BAB2448, respectively, are displayed relative
to reference sequence. Duplicated region is
boxed. Two base pairs (BAB1258) and five
base pairs (BAB2448) of microhomology were
found at the breakpoint junctions after amplifi-
cation with outward-facing primers (F and R).
(B and D) Sequence data for duplication junc-
tions; microhomologies (red letters) are boxed.
Proximal (blue for patient BAB1258, light blue
for patient BAB2448) and distal (green for
patient BAB1258, pink for patient BAB2448)
reference sequences are marked.
(E) Illustration of the predicted order, origins,
and relative orientations of duplicated se-
quences (light blue, yellow, and pink) for pa-
tient BAB2448. Arrowheads show direction of
DNA relative to the positive strand; filled arrow-
heads with circled numbers below represent
a FoSTeS event; open arrowhead signifies
resumption of replication on the original tem-
plate. Asterisk (*) indicates an unknown orien-
tation of the 170 kb segment. Proximal (cen-
tromeric) and distal (telomeric) are in relation to
PLP1 (red circle).replication machinery, causing one or multiple replication
fork stalling and switching events before resuming replica-
tion on the original DNA template.
In the vicinity of these LCR-PMDs there are also various
reported CNVs (Database of Genomic Variants, http://
projects.tcag.ca/variation/) including duplications and in-
versions (Lee et al., 2006b). As the genomic boundaries
of these CNVs do not coincide with those of the copy-
number changes and FoSTeS event locations identified
for the patients in our cohort (Figure 6A), and as the rear-
rangements were ascertained by virtue of the conveyed
PMD phenotype, these patient-associated complex rear-
rangements cannot be explained by benign CNVs.1240 Cell 131, 1235–1247, December 28, 2007 ª2007 ElsevieDISCUSSION
Junction Sequence Suggests
Replication Mechanism
We propose that the rearrangements in patients
BAB1264 and 2448 occurred via a replication-based
mechanism, which we term FoSTeS, and not via a recom-
bination-based mechanism (Figures 6B–6E). This mecha-
nism is modified from a model suggested for Escherichia
coli gene amplification (Slack et al., 2006) and similar to
that suggested for smaller rearrangements mediated by
short direct or inverted repeats that potentially form
non-B DNA conformations in various organisms (Chenr Inc.
Figure 4. Junction Analysis for Patient
BAB1264
(A) Duplication junctions (vertical dotted lines)
for patient BAB1264 are displayed relative to
reference sequence, with the duplicated region
boxed. Two or three base pairs of microhomol-
ogy were found at the breakpoint junctions af-
ter amplification with outward-facing primers
(F and R).
(B) Sequence data for the duplication junction;
microhomologies (red letters) are boxed. Prox-
imal reference sequence 1 is marked in pink,
proximal reference sequence 2 in blue, proxi-
mal reference sequence 3 in orange, and the
distal reference sequence in green.
(C) Illustration of the order, origins, and relative
orientations of junctional (pink and blue) and
boundary reference sequences (orange and
green) for patient BAB1264. Arrowheads
show direction of DNA relative to the positive
strand; filled arrowheads with circled numbers
below represent a FoSTeS event; open arrow-
head marks resumption of replication on the
original template. Proximal (centromeric) and
distal (telomeric) are in relation to PLP1 (red
circle).et al., 2005; Gordon and Halliday, 1995; Ohshima et al.,
1992; Trinh and Sinden, 1991; Wojciechowska et al.,
2005), including the generation of inversions accompa-
nied by duplications and deletions (Gordon and Halliday,
1995), and for spontaneous duplication events in eukary-
otic genome evolution (Koszul et al., 2004). In the current
model, we propose that during DNA replication, the rep-
lication fork stalls or pauses at DNA lesions resulting from
the genomic instability at/near regional LCRs. After the
replication fork stalls or pauses, the lagging strand serially
disengages and switches to another nearby template atCeanother active replication fork, which could be advancing
in either direction (50 to 30 or 30 to 50 with respect to the
leading strand); this switch would require only microho-
mology. DNA would be copied at this second (or third,
etc.) sequence, and the nascent strand might disengage
again after a short time. The forks may be in physical
proximity but separated by sizeable linear distances,
even megabases away, thus enabling the template-
driven joining of different sequences from discreet geno-
mic positions. Eventually, the replication fork would
proceed normally.ll 131, 1235–1247, December 28, 2007 ª2007 Elsevier Inc. 1241
Figure 5. Complex Rearrangement De-
tected by Oligonucleotide Array CGH
Analysis of a Previously Reported Patient
Shown are data for the carrier mother of patient
H152 (Inoue et al., 2002).
(A) An 190 kb deletion is followed by an 9 kb
segment with no copy-number change and an
interrupted 190 kb duplication.
(B) Enlargement of the 190 kb interrupted
duplication. In each horizontal yellow box
above, blue lines represent an average of the
data points. Red data points indicate copy-
number gains, green data points losses, and
black data points no copy-number change.
Log2 (Cy3/Cy5) values are on the y axis; geno-
mic position in megabases (Mb; NCBI build 35)
is on the x axis.
(C) Relative to reference sequence, junctional
sequences are highlighted; boxed are deleted
(dashed line) and duplicated (solid line) re-
gions.
(D) Illustration of the order, origins, and relative
orientations of junctional sequences for patient
H152. Asterisk (*) indicates an unknown orien-
tation of the 80 kb segment. Arrowheads
show direction of DNA relative to the positive
strand: filled arrowheads with circled numbers
below represent a FoSTeS event; open arrow-
head marks resumption of replication on the
original template. PLP1 is indicated by the
red circle.For patient BAB1264, we propose that fork stalling or
pausing, disengaging, and switching of templates may
have occurred twice, resulting in two junctional se-
quences, 32 bp and 215 bp, before resuming replication
on the original template (a total of three FoSTeS events,
or FoSTeS 3 3; Figure 4C). For patient BAB2448, we
propose that this phenomenon may have also occurred
a total of three times (FoSTeS 3 3; Figure 3E); first the
proximal 200 kb duplicated segment is copied, next
the 170 kb duplicated segment, and then the 20 kb
segment before resuming replication on the original tem-
plate. For patient BAB1258, although the rearrangement
may be explained by simple tandem duplication via
NHEJ, it is feasible that a simplified FoSTeS event may
have occurred (FoSTeS 3 1).
Physically, a close interaction between the participating
DNA molecules would be necessary, potentially aided by
the presence of highly homologous regional LCRs, cruci-
forms, or other non-B DNA structures that may form
(Bacolla and Wells, 2004; Lee et al., 2006a). This mecha-
nism may explain some of the more complex PLP1 dupli-
cation and deletion rearrangements that have been
reported in the literature (Inoue et al., 2002; Wolf et al.,
2005; Woodward et al., 2005), for which (1) additional du-
plications nearby the duplicated segment containing
PLP1 were present, (2) multiple rearrangement junctions
were identified in a single patient, (3) sequences found1242 Cell 131, 1235–1247, December 28, 2007 ª2007 Elsevier Iat the junctions were different in origin from those pre-
dicted by dosage analysis, (4) junctional sequences
were different in origin and/or orientation from those
expected from simple tandem duplication, and (5) evi-
dence for three or more copies of PLP1 was obtained in
association with a more severe PMD phenotype.
Judging from the properties of the junctional sequences
and microhomologies identified, the rearrangement in
patient H152 (and his carrier mother) might have occurred
via an NHEJ repair mechanism, as originally suggested
(Inoue et al., 2002); however, this rearrangement is also
consistent with what may occur by a FoSTeS mechanism.
Visually, a skipping forward along the chromosome is ev-
ident, followed by a skipping backward three times, for
a total of four FoSTeS events (FoSTeS 3 4; Figure 5D).
Furthermore, we confirmed by PCR and DNA sequencing
that the 34 bp junctional sequence (Figure 5C, light blue
segment) is present in two copies, one copy at the junction
and the other copy in its normal genomic position (data not
shown). Thus, not only do the junctional sequences found
for this family share identity with regions distal to the de-
leted interval in an inverted orientation, but they are also
found to be duplicated. This finding is consistent with
the rearrangement in this patient occurring via a replica-
tion-based mechanism (Figure 5D).
Such complex rearrangement products are consistent
with a mechanism of serial disengaging of a nascentnc.
Figure 6. Alignment of Proposed FoSTeS Events with Complex Genomic Architecture and Proposed FoSTeS Model
(A) Shown are genomic locations of each FoSTeS event in the context of regional LCRs (Lee et al., 2006a). Two of eleven FoSTeS events (2448-
FoSTeS1 and H152-FoSTeS3) occurred within an LCR; one additional event (H152-FoSTeS4) may have occurred either just centromeric to or just
within LCR-PMDC. Positions of CNVs found in the Database of Genomic Variants are shown as pink (duplication) and yellow (inversion) horizontal
bars. Asterisk (*) denotes that FoSTeS event position was determined under the assumption of directly ordered duplications. After encountering
a DNA lesion (B), one replication fork (dark blue and red, solid lines) with a lagging strand (red, dotted line) would invade a second fork (purple
and green, solid lines), followed by (C) DNA synthesis (green, dotted line). After the fork disengages (D), the original fork (dark blue and red, solid lines)
with its lagging strand (red and green, dotted lines) could invade a third fork (gray and black, solid lines). Dotted lines represent newly synthesized
DNA. Serial replication fork disengaging and lagging strand invasion could occur several times before (E) resumption of replication on the original
template.strand and reinitiation of DNA synthesis before the com-
pletion of DNA synthesis on the original template; this
mechanism may yield two or more copies of junctional
sequence that could be in either orientation. In contrast,
if we had identified segments of DNA that only appear at
the junctions and not in the normal genomic position,
this would have suggested a recombination-based model.
We propose that finding segments of DNA both at the
junctions and at the normal genomic position is more sug-
gestive of a template-driven event or replication-based
model. On the basis of this model, we predict that the
additional fragments at the junctions (32 bp and 215 bp)
identified for patient BAB1264 will be found in three copies
(Figures 4A and 4C).
Obtaining further junction sequence information is chal-
lenged by the complexity of the mechanism and the diffi-
culty of predicting the template structure from which toCellattempt amplification for experimental determination of
junction sequence.
Replication Model for Genomic Rearrangements
Compared to the general mechanism we have proposed
for the various PLP1 rearrangements causing PMD (Lee
et al., 2006a), our data herein suggest a single-strand
DNA lesion as the initiating damage that causes replica-
tion fork stalling, rather than a double-strand break
(DSB) that may be a more likely initiating substrate for a re-
combination-based mechanism. Repair of the DNA mole-
cule after successive template-switching events would
occur via DNA Ligase I to join Okazaki fragments (Prigent
et al., 1994). Alternatively, an initiating DSB that causes
replication fork collapse followed by repair via break-
induced replication (BIR) with multiple rounds of strand
invasions (Narayanan et al., 2006; Smith et al., 2007),131, 1235–1247, December 28, 2007 ª2007 Elsevier Inc. 1243
errors of replication fork repair involving a template switch
(Goldfless et al., 2006), and template switches involving
leading strands (Goldfless et al., 2006) cannot be ruled
out. As the nonrecurrent rearrangements causing PMD
have been reported to occur during spermatogenesis
(Inoue et al., 1999; Mimault et al., 1999), we suggest that
the replicative error may have occurred during mitotic or
meiotic DNA synthesis during the early stages (Blanco-
Rodrı´guez, 2002a, 2002b), in contrast to a recombination
model that presupposes that the causative event occurs
during the meiotic pairing of chromosomes.
Complex Rearrangements Evade Junction
Sequence Determination
From our oligo array CGH analysis, we detected complex
rearrangements in the majority (65%) of patients tested.
However, as the complex rearrangement identified by
PCR and sequence analyses in patient BAB1264 was
not detectable by oligo array CGH methodology (Fig-
ure S3), it remains possible that other patients who
appear to have simple tandem duplications by oligo array
CGH analysis might actually have experienced more com-
plex cryptic rearrangements. This may explain why
breakpoint junctions were not successfully identified for
the majority of patients in our cohort even when they
appear by oligo array CGH analysis to have simple tandem
duplications. Array CGH enables detection of genomic
regions of gains and losses but provides neither genome
position nor orientation information.
When long-range amplification across a duplication
junction fails to yield a PCR product, there are many
potential explanations. First, it is possible that the duplica-
tion is interrupted (i.e., the duplicated segment is inserted
near the original sequence) (Lee et al., 2006a). Second, the
duplication could be inverted in orientation; amplification
with outward-facing primers across a duplication junction
presumes simple tandem duplication. Third, complex du-
plications might have ends/boundaries that are not in the
orientation or location anticipated based on a simple re-
combination model (Inoue et al., 2002; Woodward et al.,
2005). Thus, although duplication (or deletion) boundaries
may be delimited successfully by a variety of methods, it is
possible that the junction(s) may not be amplified suc-
cessfully. While our semiquantitative multiplex PCR assay
successfully predicted the relative locations of junction
sequences in all patients tested (i.e., Southern analysis
detected junction fragments at predicted locations), be-
cause the duplication junctions were not successfully
obtained by numerous standard methods despite the en-
richment of DNA templates for junction sequence, we sug-
gest that these rearrangements are not simple tandem
duplications but rather are complex in nature.
The challenge we experienced in obtaining junction
sequence for the majority of our cohort is not surprising
given the regional genomic complexity involving LCRs
surrounding PLP1 (Lee et al., 2006a). This regional com-
plexity limited the resolution of our assays and potentially
contributed to a high level of genomic instability, possibly1244 Cell 131, 1235–1247, December 28, 2007 ª2007 Elseviercausing a predisposition of the PLP1 region to complex
nonrecurrent rearrangements. This challenge in obtaining
junction sequence is also reflected in the comparable suc-
cess rates reported by other groups.
However, from the novel junction sequences we ob-
tained and from our further experimentation and re-analy-
sis of a previously reported PMD case with a complex
rearrangement, we were able to (1) confirm the occur-
rence of simple tandem duplications of PLP1 and (2) pro-
pose a replication-based template switching mechanism
for human genomic rearrangements (Figures 6B–6E) to
elucidate the etiology of some of the more complex, and
potentially simple, PLP1 rearrangements that have been
reported for a subset of PMD patients.
Conclusions
Our proposed FoSTeS DNA replication model may offer
insight into the mechanism by which the DNA rearrange-
ments causing PMD, and potentially many other genomic
disorders due to nonrecurrent rearrangements, may
occur. These include: MECP2 duplications (del Gaudio
et al., 2006; Meins et al., 2005; Van Esch et al., 2005)
and triplications (del Gaudio et al., 2006) (Figure S4) caus-
ing mental retardation and seizures in males,APP duplica-
tions associated with Alzheimer’s disease (Cabrejo et al.,
2006; Rovelet-Lecrux et al., 2006), SNCA duplications
(Chartier-Harlin et al., 2004; Iba´n˜ez et al., 2004; Nishioka
et al., 2006) and triplications (Farrer et al., 2004; Polymer-
opoulos et al., 1997; Singleton et al., 2003) for Parkinson’s
disease, and a selected small fraction of complex rear-
rangements of chromosome 17 causing congenital anom-
alies and Potocki-Lupski syndrome (Potocki et al., 2007;
Vissers et al., 2007) (Figure S4).
Further, we suggest that the higher-order genomic
architecture, which may contain unusual symmetry, pres-
ent particularly in regions of nonrecurrent rearrangement,
may facilitate such faulty replication by confusing the rep-
lication machinery (causing replication fork stalling or
pausing). Likewise, the switching of templates, for which
only a microhomology is required, may be facilitated by
the same unusual complex genomic architecture due to
the resulting close proximity of highly similar DNA that
would normally be situated much further apart. Template
switching may be exacerbated by the presence of cruci-
form or other non-B DNA structures, resulting in both the
complex and noncomplex nonrecurrent rearrangements
that we and others (Kosmider and Wells, 2007) observe.
The concept of a replication-based as opposed to a re-
combination-based mechanism revolutionizes our think-
ing about nonrecurrent DNA rearrangements and how
they may physically occur. The FoSTeS replication-based
mechanism may be responsible for other disease-causing
genomic rearrangements, gene duplications affecting
immediate and long-term genome evolutionary changes
(Dumas et al., 2007; Ohno, 1970) including the emergence
of novel gene function, the generation of advantageous
and/or benign CNVs (Redon et al., 2006) in response to
environmental factors, as well as the generation ofInc.
complex segmental duplications or regional LCRs. Thus,
such ‘‘errors of replication’’ may provide a mechanism
for the maintenance of genome plasticity and, conceivably
over longer periods of time, genome evolution.
EXPERIMENTAL PROCEDURES
Patients
We analyzed 17 unrelated individuals (Table 1) from our cohort of male
patients with PMD, excluding any family members who might give
redundant junction sequence data, to perform extensive duplication
junction mapping analyses using several independent experimental
approaches; eight of these males showed no evidence of a complex
PLP1 duplication rearrangement by various methods (Lee et al.,
2006a). The majority of patients has been described previously (Inoue
et al., 1999, 2002; Raskind et al., 1991); newly acquired patient sam-
ples were obtained with informed consent approved by the Institu-
tional Review Board for Human Subject Research at Baylor College
of Medicine. Patient DNA was isolated either directly from peripheral
blood using a Puregene kit (Gentra) or from transformed lymphoblas-
toid cell lines by standard phenol/chloroform extraction.
Semiquantitative PCR Analysis
To map the extent of genomic duplication finely in eight selected
patients (Table 1), we performed semiquantitative PCR analysis using
a series of primer pairs multiplexed with a control primer set (Table
S3B) amplifying the dystrophin gene using a Multiplex PCR Kit
(QIAGEN) and following the manufacturer’s instructions, except that
the PCR reactions were set to amplify for only 25 cycles with an anneal-
ing temperature of 60C. To determine dosage of PLP1 and also of var-
ious other interrogated flanking regions, amplicon intensities for each
test primer pair were first normalized to the intensity of the dystrophin
product and then to the average amplicon intensity for three male con-
trols. PCR reactions were electrophoresed on 4% NuSieve 3:1 aga-
rose gels (Cambrex Bioscience), and amplicon intensities were
measured using an Alpha Innotech ChemiImager 5500 imaging system
with accompanying AlphaEase FC molecular imaging software (Alpha
Innotech Corporation).
Long-RangePCRAmplification usingPrimers Facing outward
Junction regions were delineated to within a genomic interval consid-
ered feasible for long-range PCR (i.e., 2–16 kb). Assuming tandem
duplications (Inoue et al., 1999), and using outward-facing primers
(with respect to reference sequence), long-range PCR was performed
using Phusion high-fidelity polymerase with GC buffer (Finnzymes Oy),
with and without DMSO (see Results and Table S1). The maximum dis-
tance between outward-facing primers was calculated as delineated
by semiquantitative multiplex PCR and was used to determine primer
extension time. The reaction conditions were as follows: 98C for 30 s,
followed by 35 cycles of 98C for 10 s, 60C for 30 s, and 72C for
30 s per kb, followed by 72C for 10 min. Amplification products
were electrophoresed on 0.8%–1% agarose gels and DNA from any
unique bands were analyzed by DNA sequencing.
Probe Design and Preparation for Southern Blot Analysis
For Southern blot analysis for each patient, unique primers were
designed to construct DNA probes that would hybridize to the most
distal and/or most proximal ends of the duplication, when possible
given the availability of nonrepetitive and nonrepeat sequence. Primer
names and sequences, and amplicon sizes and positions, are listed in
Table S2. PCR products were purified by gel extraction using a QIAEX
II Gel Extraction Kit (QIAGEN).
Southern Blot Analysis
Overnight single digests of 5 mg of patient genomic DNA with several
restriction enzymes (Invitrogen; New England Biolabs; Table S2)Cellwere electrophoresed on 0.8% agarose gels at 100 V for 5 hr. Size-
fractionated DNA was transferred to a positively charged Sure Blot
Nylon Membrane (Intergen Company) using alkaline transfer buffer
(0.4 N NaOH/1 M NaCl) overnight. Agarose gels were depurinated
briefly (0.2 N HCl) if target bands were >20 kb. Membranes were neu-
tralized (0.5 M Tris-Cl [pH 7.2]/1 M NaCl) for 15 min, and the transferred
DNA was fixed to wet membranes using a UV Stratalinker 2400
(Stratagene).
Approximately 25 ng of probe DNA were labeled with 32P-dCTP (MP
Biomedicals) for 1 hr at 37C using a Rediprime II Random Prime
Labeling System (Amersham Biosciences) according to the manufac-
turer’s instructions. Labeled probes were purified using MicroSpin
G-50 columns (Amersham Biosciences). Membranes were prehybri-
dized at 65C in a prewarmed solution consisting of 19 ml dH2O,
2 ml 10% milk, 4 ml 10% SDS, 3 ml 203 SSPE, and 0.5 ml salmon
sperm DNA (denatured by boiling for 10 min) for at least 1 hr and
hybridized overnight at 65C in a pre-warmed solution consisting of
11.4 ml dH2O, 4 ml 50% dextran sulfate, 1 ml 10% milk, 2 ml 10%
SDS, and 1.5 ml 203 SSPE. Membranes were washed in 23 SSC/
0.1% SDS at room temperature, 45C, and 65C. Hybridized blots
were analyzed by autoradiography for the presence of bands of
expected size and also for bands of varying size, potentially represent-
ing junction fragments. Blots were stripped and rehybridized as
necessary.
Long-Range PCR Amplification using Primers Facing Either
One Direction or inward
To include the possibility of small inversions at breakpoint junctions,
PCR amplification was attempted using gene-specific primers
(GSPs) or the furthest primers that detected a DNA duplication result
for each patient as defined by semiquantitative multiplex PCR, both
(1) singly or paired facing only one direction and (2) paired facing
inward. Phusion high-fidelity polymerase with HF buffer (Finnzymes
Oy) was used to amplify template DNA enriched for junction sequence
under the following reaction conditions: 98C for 30 s, followed by
10 cycles of 98C for 10 s, 65C for 30 s (minus 1C per cycle), 72C
for 30 s per kb, followed by 30 cycles of 98C for 10 s, 55C for 30 s,
and 72C for 30 s per kb, followed by 72C for 10 min. Reactions
were electrophoresed on 0.8%–1% agarose gels and DNA from any
unique bands were analyzed by DNA sequencing.
High-Resolution Genome Analysis by Oligonucleotide Array
Comparative Genomic Hybridization
To obtain higher resolution of duplication breakpoint junctions than
afforded by semiquantitative multiplex PCR and BAC array CGH, we
applied oligo array CGH using an Agilent Technologies custom micro-
array in 4344K format (#G4426A) to our larger cohort of patients (Ta-
ble 1). Using the Agilent eArray tool, we selected 24,643 60-mer probes
spanning 10 Mb including PLP1 (chrX:97,835,000–107,855,000,
NCBI build 35). Probe labeling and hybridization were performed fol-
lowing the manufacturer’s protocol (Agilent Oligonucleotide Array-
based CGH for Genomic DNA analysis, version 4.0 plus the 4344K
complementary protocol with modifications unique to the four-pack
format).
Briefly, 1.5 mg of genomic male/female reference and patient DNA
were digested with AluI (5 U) and RsaI (5 U) (Promega) for 2 hr
at 37C. Digestions were verified by agarose gel electrophoresis.
Labeling reactions with Cy5-dUTP for patient DNA and Cy3-dUTP
for male/female reference DNA were performed according to the man-
ufacturer’s instructions (Agilent Genomic DNA Labeling Kit Plus,
#5188-5309). Individual dye-labeled reference and patient samples
were purified using Microcon Ym-30 filters (Millipore Corporation).
DNA yield was determined using a NanoDrop ND-1000 UV-VIS spec-
trophotometer. Each dye-labeled patient and gender-matched refer-
ence DNA was combined with 5 mg human Cot-1 DNA (Invitrogen
Corporation), 13 Agilent Blocking Agent, and 13 Agilent hybridization
buffer (#5188-5220). These mixtures were denatured at 95C for 3 min,131, 1235–1247, December 28, 2007 ª2007 Elsevier Inc. 1245
preincubated at 37C for 30 min, and hybridized to the array in a hybrid-
ization chamber (Agilent Technologies) for 40 hr at 65C in a rotating
oven (Agilent Technologies). Array slides were washed using Agilent
Wash solutions 1 and 2 (#5188-5226), Acetonitrile (Sigma-Aldrich),
and Stabilization and Drying Solution (#5185-5979), according to the
manufacturer’s instructions. Slides were scanned on a GenePix
4000B Microarray Scanner (Axon Instruments). Images were analyzed
and data were extracted, background subtracted, and normalized
using Agilent Feature Extraction Software A.7.5.1. These data were
subsequently imported into array CGH analytics software v3.1.28
(Agilent Technologies).
Using these high-resolution data, a new set of primers was designed
at the apparent boundaries of each duplicated segment(s) (as deter-
mined by a transition from normal copy number to gain in copy num-
ber) for all patients except those for whom breakpoint junctions had
already been sequenced (i.e., BAB1258 and 1264) and used for
long-range PCR amplification as described above (primers facing out-
ward, inward, and in the same direction). When more than one dupli-
cated segment was identified for a given patient, primers facing
outward, inward, and the same direction at the boundaries of each
segment were paired in all various predicted combinations.
DNA Sequencing Analysis
PCR amplicons that potentially contained junction sequences were
purified either with a QIAquick PCR Purification Kit (QIAGEN) or
a QIAEX II Gel Extraction Kit (QIAGEN), following the manufacturer’s
instructions. Purified amplicons and PCR amplification primers were
submitted to SeqWright DNA Technology Services or Lone Star
Labs (Houston, TX), where DNA sequencing was performed by stan-
dard Sanger dideoxy and automated fluorescence methods. Patient
DNA sequences were analyzed by comparing to reference sequences,
with the use of the UCSC Genome Browser (http://genome.ucsc.edu/;
Kent et al., 2002) and BLAST (nucleotide-nucleotide BLAST and
BLAST for short, nearly exact matches).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
three tables, and three figures and can be found with this article online
at http://www.cell.com/cgi/content/full/131/7/1235/DC1/.
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